https://wikimd.com/index.php?action=history&feed=atom&title=Virtual_screeningVirtual screening - Revision history2026-04-07T12:57:16ZRevision history for this page on the wikiMediaWiki 1.44.2https://wikimd.com/index.php?title=Virtual_screening&diff=5615274&oldid=prevPrab: CSV import2024-04-16T18:06:14Z<p>CSV import</p>
<p><b>New page</b></p><div>[[File:FlowChart.png|FlowChart|thumb]] '''Virtual screening''' (VS) is a computational technique used in [[drug discovery]] to search large libraries of small molecules in order to identify those structures which are most likely to bind to a [[drug target]], typically a [[protein]] receptor or enzyme. Virtual screening has become an integral part of the drug discovery process as it allows for the rapid and cost-effective identification of potential drug candidates before they are synthesized and tested in [[laboratory]] experiments.<br />
<br />
==Overview==<br />
Virtual screening involves the use of computer simulations to estimate the affinity of a large number of compounds for a given biological target. The process can be divided into two main types: structure-based virtual screening (SBVS) and ligand-based virtual screening (LBVS).<br />
<br />
===Structure-Based Virtual Screening===<br />
SBVS, also known as [[docking]], relies on the knowledge of the three-dimensional structure of the biological target obtained through methods such as [[X-ray crystallography]] or [[NMR spectroscopy]]. Compounds are computationally "docked" into the binding site of the target protein, and their potential binding affinity is evaluated using scoring functions.<br />
<br />
===Ligand-Based Virtual Screening===<br />
LBVS does not require knowledge of the target structure but instead uses information from known active compounds to identify new ligands. Techniques used in LBVS include [[quantitative structure-activity relationship]] (QSAR) modeling, [[pharmacophore]] modeling, and similarity searching.<br />
<br />
==Applications==<br />
Virtual screening is widely used in the pharmaceutical industry to enhance the efficiency of the drug discovery process. It is applied in the identification of lead compounds in the early stages of drug development, optimization of lead compounds, and investigation of the mechanism of action of drugs.<br />
<br />
==Challenges and Future Directions==<br />
Despite its advantages, virtual screening faces several challenges, including the accuracy of scoring functions in predicting binding affinity, the handling of protein flexibility, and the need for large computational resources. Ongoing research in the field aims to address these issues through the development of more sophisticated algorithms, the integration of artificial intelligence and machine learning techniques, and the use of cloud computing to improve the scalability of virtual screening campaigns.<br />
<br />
[[Category:Computational Chemistry]]<br />
[[Category:Drug Discovery]]<br />
[[Category:Pharmacology]]<br />
<br />
{{stb}}</div>Prab